The elimination of indigenous measles transmission in England and Wales

Journal of Infectious Diseases

Volumn 187, Issue SUPPL. 1, 2003, Pages

  Ramsay, Mary E ^a   Jin, Li ^b   White, Joanne ^a   Litton, Pam ^b   Cohen, Bernard ^b   Brown, David ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; BODY FLUID; CHILD; DISEASE TRANSMISSION; GENOTYPE; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; PRIORITY JOURNAL; SALIVA; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DNA, VIRAL; ENGLAND; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; POLYMERASE CHAIN REACTION; SALIVA; WALES;

EID: 0037986347     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368024     Document Type: Article

References (28)

1. Ramsay M, Gay N, Miller E, et al. The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev 1994; 4:R141-6.
2. de Quadros C, Olive J, Hersh B, et al. Measles elimination in the Americas evolving strategies. JAMA 1996; 275:224-9.
3. Anonymous. Role of mass campaigns in global measles control. Global Programme for Vaccines of the World Health Organization. Lancet 1994; 344:174-5.
4. Salisbury DM, Horsley SD. Measles campaign. BMJ 1995; 310:1334.
5. De Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000; 151:1039-48.
6. Brown DW, Ramsay ME, Richards AF, Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ 1994; 308:1015-7.
7. Ramsay M, Brugha R, Brown D. Surveillance of measles in England and Wales: implications of a national saliva testing programme. Bull World Health Organ 1997; 75:515-21.
8. Jin L, Richards A, Brown D. Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens. Molec Cell Probes 1996; 10:191-200.
9. Jin L, Brown DW, Ramsay ME, Rota PA, Bellini WJ. The diversity of measles virus in the United Kingdom, 1992-1995. J Gen Virol 1997; 78:1287-94.
10. Ramsay M, Cohen B, Brown D. Serum IgM testing is needed in all cases of suspected measles. BMJ 1996; 313:231.
11. Anonymous. Expanded Programme on Immunization (EPI). Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Wkly Epidemiol Rec 1998; 73:265-9.
12. Jin L, Sun YJ, Ge L, Brown DW. Characterization of a new genotype of measles virus detected in China and England. Epidemiol Infect 1998; 121:691-7.
13. Hanratty B, Holt T, Duffell E, et al. UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe. Epidemiol Infect 2000; 125:377-83.
14. Anonymous. Outbreaks of measles in communication with low vaccine coverage. Commun Dis Rep CDR Wkly 2000; 10:29.
15. Hanses F, van Binnendijk R, Ammerlaan W, et al. Genetic variability of measles viruses circulating in the Benelux. Arch Virol 2000; 145:541-51.
16. Santibanez S, Heider A, Gerike E, Agafonov A, Schreier E. Genotyping of measles virus isolates from central Europe and Russia. J Med Virol 1999; 58:313-20.
17. Rima BK, Earle JA, Baczko K, et al. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol 1997; 78:97-106.
18. World Health Organization. WHO vaccine preventable diseases: monitoring system. 2000 global summary. Geneva: WHO, 2000 (WHO/V&B/00.32).
19. Bellini WJ, Rota PA. Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis 1998; 4:29-35.
20. Anonymous. Nomenclature for describing the genetic characteristics of wild-type measles viruses (update). Part I. Wkly Epidemiol Rec 2001; 76:242-7.
21. Nigatu W, Jin L, Cohen B, et al. Measles virus strains circulating in Ethopia in 1998-1999: molecular characterisation using oral fluid samples and identification of a new genotype. J Med Virol 2001; 65:373-80.
22. Kreis S, Vardas E, Whistler T. Sequence analysis of the nucleocapsid gene of measles virus isolates from South Africa identifies a new genotype. J Gen Virol 1997; 78:1581-7.
23. de Swart RL, Wertheim-Van Dillen PM, van Binnendijk RS, Muller CP, Frenkel J, Osterhaus AD. Measles in a Dutch hospital introduced by an immuno-compromised infant from Indonesia infected with a new virus genotype. Lancet 2000; 355:201-2.
24. Hinman AR, Orenstein WA, Papania MJ. Invited commentary: epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000; 151:1049-52.
25. Gay N, Ramsay M, Cohen B, et al. The epidemiology of measles in England and Wales since the 1994 vaccination campaign. Commun Dis Rep CDR Rev 1997; 7:R17-21.
26. Chief Medical Officer. Measles, measles mumps rubella (MMR) vaccine, Crohn's disease, and autism. London: Department of Health, 1998 (PL/CMO/98/2).
27. Hersh BS, Tambini G, Nogueira AC, de Quadros CA. Review of regional measles surveillance data in the Americas, 1996-99. Lancet 2000; 355:1943-8.
28. Ramsay M. A strategic framework for the elimination of measles in the European Region. Copenhagen: Expanded Programme on Immunization in the European Region of WHO, 1999 (EUR/ICP/CMDS 01 01 05).